Fox Chase Cancer Center Appoints Robert G. Uzzo, M.D., a Member in Department of Surgical Oncology
PHILADELPHIA (March 6, 2003) — Robert G. Uzzo, MD, of Maple Glen, Pa., has been appointed a member of the division of medical science at Fox Chase Cancer Center. Becoming a member, the equivalent of tenure at a university, requires a recommendation based on a review of the scientist's work by his or her peers.
Uzzo joined Fox Chase's department of surgical oncology in 2000 as an attending surgeon. His interests focus on treatment for kidney, prostate, testicular and bladder cancer and procedures for urinary diversion. He is skilled in minimally invasive procedures such as endoscopy and laparoscopy for certain bladder and kidney tumors, urethral blockages and lymph-node dissection for genitourinary cancers.
"Dr. Uzzo has been a major contributor to clinical excellence in urologic oncology and has brought innovative urologic techniques to the clinical service," said surgical oncology chairman Burton L. Eisenberg, M.D. "In addition to his notable clinical skills, he has made a substantial commitment to urologic research."
Before joining Fox Chase, Uzzo was a fellow and a member of the clinical staff in the department of urology at the Cleveland Clinic Foundation from 1997 to 2000. He was an American Foundation for Urologic Diseases scholar there from 1997 to 1999 and held an additional fellowship in renal transplantation and renovascular surgery at the Cleveland Clinic from 1999 to 2000.
Uzzo earned his bachelor's degree summa cum laude in biology and anthropology at Union College in Schenectady, N.Y., and his M.D. in 1991 at Cornell University Medical College in New York City. He was valedictorian of his Union College Class of 1989 and was elected to Phi Beta Kappa there. He also earned the Daggett Prize in the Anatomies and was a New York State finalist in the Rhodes Scholarship competition.
As a senior medical student at Cornell in 1990, he elected to study pediatric kidney problems (nephrology) at Guy's Hospital in London, England, and went on to spend two months in Russia studying at the Urologic Institute of Moscow. He also served as a primary care physician for the National Public Health Service at Kayenta Navajo Indian Reservation in Arizona.
Uzzo served his internship and residency in surgery at the New York Hospital - Cornell University Medical Center. He continued his residency in urology at Cornell and at Memorial Sloan-Kettering Cancer Center from 1993 to 1997, serving as chief resident in New York Hospital's department of urology from 1996 to 1997.
In 1997, he also served as ship's physician for a six-week explorer expedition to Antarctica before beginning his American Foundation for Urologic Diseases fellowship at the Cleveland Clinic. Other honors during his postgraduate training included the Pfizer Physician Scholar in Urology in 1998 and again in 2000; the American Urology Association's Circon Award, first place in 1999 and honorable mention in 1996; and a 1999 Young Investigator Award from the American Association of Cancer Research. He is a co-author of more than 65 peer-reviewed articles and chapters.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.